New Scientific Advisory Appointments

Cure Alzheimer's Fund Appoints Four Expert Scientists to Its Scientific Advisory Board

CureAlz has announced the appointments of Drs. Michelle Arkin, Ronald B. DeMattos, Donna M. Huryn, and Kalpana Merchant to its Scientific Advisory Board (SAB), which provides strategic guidance on CureAlz's scientific direction and research investment strategy. The SAB members have decades of experience in target identification, drug discovery, and clinical development of Alzheimer's treatments. CureAlZ does not accept funding from pharmaceutical or biotech companies but values the SAB's expertise.